Results 231 to 240 of about 2,858,598 (299)

Unlimited Smartphone Data Plans in Older Adults With Data Deprivation: Quasi-Experimental Study.

JMIR Mhealth Uhealth
Choi S, Choi E, Jang SY.
europepmc   +1 more source

Comparison of national health planning policies in China and ASEAN: a PMC-index model analysis. [PDF]

Cost Eff Resour Alloc
Feng J, Zhu C, Chen Y, Huang L, Huang Q, Qin Y, Wei J, Li Z, Feng Q, Qin X, Kang J.   +10 more
europepmc   +1 more source

School support staff training and development: our plans for 2004-05 [PDF]

core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Checkpoint blockade and the stem‐like T cell trade‐off

Molecular Oncology, EarlyView.
Stem‐like T cells are key to the success of programmed cell death protein 1 (PD1) blockade, as they sustain long‐term anti‐tumor response by continuously generating effector CD8+ T cells. However, how these cells are maintained in cancer is not fully understood. Hor et al.
Julie M. Mazet, Johanna A. Joyce
wiley   +1 more source

Application of digital technology in medical practice. [PDF]

Front Public Health
Gu L, Chen L, Ma C.
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Facilitators and barriers to the formulation of public policies on food and nutrition: A scoping review. [PDF]

PLOS Glob Public Health
Feldenheimer da Silva AC, Fagundes AA, Curioni CC, Ribeiro de Sá CC, Buccini G, Pereira-Castro MR, Lopes MS, Rocha LL, Pereira FMN, Recine E.   +9 more
europepmc   +1 more source

Development and implementation of an MRI-only simulation, planning, and treatment workflow for prostate radiotherapy using synthetic CT on MR-linac. [PDF]

J Appl Clin Med Phys
Reiazi R, Ding Y, Vijayan S, Yang J, Subashi E, Zhao Y, Lee BM, Emory HL, Dinh VT, Swiedom GL, Deng J, Lin MH, Balter P, Kudchadker RJ, Cha EE, Choi S, Kim Y, Han EY, Prajapati S.   +18 more
europepmc   +1 more source

Can knowledge-based autoplanning keep up with advances in radiotherapy optimization for oropharyngeal cancer? [PDF]

Front Oncol
Panettieri V, Olumuyiwa O, Södergren L, Söderström J, Bolin MC, Falk M, Embring A, Onjukka E.   +7 more
europepmc   +1 more source